HAEMONETICS CORP Quarterly Deferred Income Tax Assets, Net in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
Haemonetics Corp quarterly Deferred Income Tax Assets, Net history and growth rate from Q1 2019 to Q3 2024.
  • Haemonetics Corp Deferred Income Tax Assets, Net for the quarter ending September 28, 2024 was $9.08M, a 91.4% increase year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $9.08M +$4.34M +91.4% Sep 28, 2024 10-Q 2024-11-07
Q2 2024 $9.37M +$4.49M +92.2% Jun 29, 2024 10-Q 2024-08-08
Q1 2024 $7.74M +$2.5M +47.7% Mar 30, 2024 10-Q 2024-11-07
Q4 2023 $5.07M +$228K +4.71% Dec 30, 2023 10-Q 2024-02-08
Q3 2023 $4.75M +$463K +10.8% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $4.88M +$323K +7.1% Jul 1, 2023 10-Q 2023-08-08
Q1 2023 $5.24M +$773K +17.3% Apr 1, 2023 10-K 2024-05-20
Q4 2022 $4.84M -$1.21M -20% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $4.28M -$1.78M -29.4% Oct 1, 2022 10-Q 2022-11-08
Q2 2022 $4.55M -$1.65M -26.5% Jul 2, 2022 10-Q 2022-08-10
Q1 2022 $4.47M -$1.54M -25.6% Apr 2, 2022 10-K 2023-05-22
Q4 2021 $6.05M +$1.49M +32.7% Jan 1, 2022 10-Q 2022-02-08
Q3 2021 $6.06M +$1.76M +40.8% Oct 2, 2021 10-Q 2021-11-09
Q2 2021 $6.2M +$2.11M +51.6% Jul 3, 2021 10-Q 2021-08-11
Q1 2021 $6.01M +$2.08M +52.9% Apr 3, 2021 10-K 2022-05-25
Q4 2020 $4.56M Dec 26, 2020 10-Q 2021-02-02
Q3 2020 $4.31M Sep 26, 2020 10-Q 2020-11-04
Q2 2020 $4.09M Jun 27, 2020 10-Q 2020-08-04
Q1 2020 $3.93M -$429K -9.84% Mar 28, 2020 10-K 2021-05-26
Q1 2019 $4.36M Mar 30, 2019 10-K 2020-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.